APOE2/2基因型与脉络膜厚度降低相关
本研究前瞻性招募年龄性别匹配的APOE2/2与APOE3/3个体各12例,比较黄斑结构与功能。结果显示APOE2/2组甘油三酯显著更高,且在多变量分析后脉络膜厚度较APOE3/3组减少57.8微米(P=0.02),而视力、视网膜敏感度无差异。
要点
- APOE2/2纯合子个体脉络膜厚度较APOE3/3对照组显著降低。
- APOE2/2组血清甘油三酯水平显著高于APOE3/3组。
- 两组间最佳矫正视力、低亮度视力及视网膜敏感度无显著差异。
核心结论
- APOE2/2纯合子与脉络膜厚度降低存在新的基因型-表型关联。
研究设计与样本
- 前瞻性招募年龄和性别匹配的APOE2/2与APOE3/3个体各12例,共24例,平均年龄60.5±5.7岁,女性男性各半,87.5%不吸烟。
- 进行最佳矫正视力、低亮度视力、微视野、屈光检查、多模态视网膜成像、空腹血脂和饮食问卷评估。
- 采用线性混合模型分析配对眼测量,纳入年龄、性别、吸烟状态和屈光误差为协变量。
主要发现
- APOE2/2组血清甘油三酯显著高于APOE3/3组(1.8 vs. 1.03 mM,P=0.010)。
- 多变量分析控制年龄、性别、吸烟状态和屈光误差后,APOE2/2组脉络膜厚度较APOE3/3组减少57.8微米(P=0.02)。
- OCT分割显示APOE2/2组视网膜厚度有降低趋势但未达统计学显著性。
- 最佳矫正视力、低亮度视力及视网膜敏感度在两组间无差异。
- 饮食和背景AMD遗传风险在两组间相当。
关键数值与推荐
- APOE2/2组血清甘油三酯为1.8 mM,APOE3/3组为1.03 mM,P=0.010。
- 脉络膜厚度估计差异为57.8微米,P=0.02。
临床怎么用
- 对于APOE2/2基因型个体,临床评估时应关注脉络膜厚度变化,可能提示AMD风险相关表型。
- APOE2/2个体血脂管理可能需重视,因其甘油三酯水平较高。
局限性
- 样本量较小,仅24例参与者。
- 视网膜厚度降低趋势未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Age-related macular degeneration (AMD) is a leading cause of visual impairment in individuals >50 years. The APOE2 allele has been associated with increased AMD risk compared to the common APOE3 allele. However, the retinal phenotype of APOE2/2 individuals has not been characterized. This study aimed to compare the macular structure and function of APOE2/2 versus APOE3/3 homozygous individuals. METHODS: Age- and sex-matched participants with APOE2/2 and APOE3/3 genotypes were prospectively recruited from the Oxford Biobank. Phenotyping included best-corrected visual acuity (BCVA), low-luminance visual acuity (LLVA), microperimetry, refractive error, multimodal retinal imaging, fasting lipid profile, and EPIC-Norfolk food frequency questionnaires. A linear mixed model of paired eye measurements with a subject-specific random intercept was applied, including age, sex, smoking status and refractive error as covariates. Findings were compared to similar UK Biobank cohorts. RESULTS: 24 participants were recruited: 12 APOE2/2 and 12 APOE3/3 (mean age 60.5 ± 5.7 (standard deviation) years, female/male 1:1; 87.5% non-smokers). Serum triglycerides were significantly higher in APOE2/2 participants (1.8 vs. 1.03 mM, P = 0.010). A novel finding of reduced choroidal thickness was found in APOE2/2 compared to APOE3/3 participants after multivariate analysis controlling for age, sex, smoking status and refractive error (estimated difference 57.8 µm, P = 0.02). Optical coherence tomography segmentation showed a trend toward reduced retinal thickness in APOE2/2 compared to APOE3/3 participants, but did not reach statistical significance. No differences in BCVA, LLVA, or retinal sensitivity were detected. Diet and background AMD genetic risk were comparable. CONCLUSIONS: We report a novel genotype-phenotype association of reduced choroidal thickness in individuals homozygous for APOE2/2 compared with normative APOE3/3 controls.
引用
- Borchert GA, Ferreira LAF, Raji S, et al. Apolipoprotein E2/2 (APOE2/2) Genotype Is Associated With Reduced Choroidal Thickness. Invest Ophthalmol Vis Sci. 2026. PMID: 42757924. doi:10.1167/iovs.67.11.38
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。